Sheng D, Yue C, Jin F, Wang Y, Ichikawa M, Yu Y
Elife. 2024; 12.
PMID: 38578670
PMC: 10997329.
DOI: 10.7554/eLife.92829.
Dunwiddie T, Abbracchio M, Bischofberger N, Brundege J, Buell G, Collo G
Drug Dev Res. 2024; 39(3-4):361-370.
PMID: 38283105
PMC: 10821783.
DOI: 10.1002/(sici)1098-2299(199611/12)39:3/4<361::aid-ddr17>3.0.co;2-4.
Shen C, Zhang Y, Cui W, Zhao Y, Sheng D, Teng X
Nat Commun. 2023; 14(1):6437.
PMID: 37833294
PMC: 10575874.
DOI: 10.1038/s41467-023-42164-y.
Biringer R
Mol Cell Biochem. 2023; 478(12):2813-2848.
PMID: 36947357
DOI: 10.1007/s11010-023-04701-7.
Sophocleous R, Ooi L, Sluyter R
Int J Mol Sci. 2022; 23(10).
PMID: 35628550
PMC: 9147237.
DOI: 10.3390/ijms23105739.
Role of microglia and P2X4 receptors in chronic pain.
Kohno K, Tsuda M
Pain Rep. 2021; 6(1):e864.
PMID: 33981920
PMC: 8108579.
DOI: 10.1097/PR9.0000000000000864.
Contribution of P2X4 receptor in pain associated with rheumatoid arthritis: a review.
Khir N, Noh A, Shafin N, Ismail C
Purinergic Signal. 2021; 17(2):201-213.
PMID: 33594635
PMC: 8155137.
DOI: 10.1007/s11302-021-09764-z.
Contribution of P2X4 Receptors to CNS Function and Pathophysiology.
Montilla A, Mata G, Matute C, Domercq M
Int J Mol Sci. 2020; 21(15).
PMID: 32756482
PMC: 7432758.
DOI: 10.3390/ijms21155562.
Increased surface P2X4 receptor regulates anxiety and memory in P2X4 internalization-defective knock-in mice.
Bertin E, Deluc T, Pilch K, Martinez A, Pougnet J, Doudnikoff E
Mol Psychiatry. 2020; 26(2):629-644.
PMID: 31911635
DOI: 10.1038/s41380-019-0641-8.
Mapping the binding site of the P2X receptor antagonist PPADS reveals the importance of orthosteric site charge and the cysteine-rich head region.
Huo H, Fryatt A, Farmer L, Schmid R, Evans R
J Biol Chem. 2018; 293(33):12820-12831.
PMID: 29997254
PMC: 6102130.
DOI: 10.1074/jbc.RA118.003737.
The TWIK2 Potassium Efflux Channel in Macrophages Mediates NLRP3 Inflammasome-Induced Inflammation.
Di A, Xiong S, Ye Z, Malireddi R, Kometani S, Zhong M
Immunity. 2018; 49(1):56-65.e4.
PMID: 29958799
PMC: 6051907.
DOI: 10.1016/j.immuni.2018.04.032.
Reduced expression of purinergic P2X4 receptors increases voluntary ethanol intake in C57BL/6J mice.
Khoja S, Huynh N, Asatryan L, Jakowec M, Davies D
Alcohol. 2018; 68:63-70.
PMID: 29477921
PMC: 5878121.
DOI: 10.1016/j.alcohol.2017.09.004.
P2X4 Receptor Function in the Nervous System and Current Breakthroughs in Pharmacology.
Stokes L, Layhadi J, Bibic L, Dhuna K, Fountain S
Front Pharmacol. 2017; 8:291.
PMID: 28588493
PMC: 5441391.
DOI: 10.3389/fphar.2017.00291.
P2X4 Receptor Reporter Mice: Sparse Brain Expression and Feeding-Related Presynaptic Facilitation in the Arcuate Nucleus.
Xu J, Bernstein A, Wong A, Lu X, Khoja S, Yang X
J Neurosci. 2016; 36(34):8902-20.
PMID: 27559172
PMC: 4995303.
DOI: 10.1523/JNEUROSCI.1496-16.2016.
Microglial P2 Purinergic Receptor and Immunomodulatory Gene Transcripts Vary By Region, Sex, and Age in the Healthy Mouse CNS.
Crain J, Watters J
Transcr Open Access. 2016; 3(2).
PMID: 26949719
PMC: 4777314.
DOI: 10.4172/2329-8936.1000124.
Insights into the channel gating of P2X receptors from structures, dynamics and small molecules.
Wang J, Yu Y
Acta Pharmacol Sin. 2016; 37(1):44-55.
PMID: 26725734
PMC: 4722974.
DOI: 10.1038/aps.2015.127.
Roles of the lateral fenestration residues of the P2X₄ receptor that contribute to the channel function and the deactivation effect of ivermectin.
Gao C, Yu Q, Xu H, Zhang L, Liu J, Jie Y
Purinergic Signal. 2015; 11(2):229-38.
PMID: 25847072
PMC: 4425721.
DOI: 10.1007/s11302-015-9448-5.
Key sites for P2X receptor function and multimerization: overview of mutagenesis studies on a structural basis.
Hausmann R, Kless A, Schmalzing G
Curr Med Chem. 2014; 22(7):799-818.
PMID: 25439586
PMC: 4460280.
DOI: 10.2174/0929867322666141128163215.
Use of chimeras, point mutants, and molecular modeling to map the antagonist-binding site of 4,4',4″,4‴-(carbonylbis-(imino-5,1,3-benzenetriylbis(carbonylimino)))tetrakisbenzene-1,3-disulfonic acid (NF449) at P2X1 receptors for ATP.
Farmer L, Schmid R, Evans R
J Biol Chem. 2014; 290(3):1559-69.
PMID: 25425641
PMC: 4340402.
DOI: 10.1074/jbc.M114.592246.
P2X4 receptors (P2X4Rs) represent a novel target for the development of drugs to prevent and/or treat alcohol use disorders.
Franklin K, Asatryan L, Jakowec M, Trudell J, Bell R, Davies D
Front Neurosci. 2014; 8:176.
PMID: 25009459
PMC: 4068020.
DOI: 10.3389/fnins.2014.00176.